You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tetanus antitoxin

Showing 1 - 25 of 298
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tetanus Trial in Ho Chi Minh (Human tetanus immunoglobulin, Intramuscular antitoxin)

Completed
  • Tetanus
  • Human tetanus immunoglobulin
  • Intramuscular antitoxin
  • Ho Chi Minh, Vietnam
    Hospital for Tropical Diseases
May 28, 2020

Tetanus Trial in China (TNM002, Human tetanus immunoglobulin (HTIG))

Recruiting
  • Tetanus
  • TNM002
  • Human tetanus immunoglobulin (HTIG)
  • Hefei, Anhui, China
  • +29 more
Jan 19, 2023

Diphtheria, Tetanus Trial in Korea, Republic of (BR-TD-1001, Td-pur inj)

Completed
  • Diphtheria
  • Tetanus
  • BR-TD-1001
  • Td-pur inj
  • Changwon, Korea, Republic of
  • +8 more
Nov 18, 2020

Safety Issues Trial in Surabaya (Diphtheria Antitoxin)

Completed
  • Safety Issues
  • Diphtheria Antitoxin
  • Surabaya, East Java, Indonesia
    RSUD Dr. Soetomo
Sep 19, 2023

Diphtheria, Tetanus and Acellular Pertussis Trial (Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined

Not yet recruiting
  • Diphtheria, Tetanus and Acellular Pertussis
  • Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP)
  • +4 more
  • (no location specified)
Jul 10, 2023

Tetanus Trial in Shangqiu (Investigational tetanus vaccine, adsorbed, Control tetanus vaccine, adsorbed)

Recruiting
  • Tetanus
  • Investigational tetanus vaccine, adsorbed
  • Control tetanus vaccine, adsorbed
  • Shangqiu, Henan, China
    Liangyuan District Center for Disease Control and Prevention
Sep 15, 2023

Tetanus Trial in China (TNM002 (low dose), TNM002 (medium dose), TNM002 (high dose))

Completed
  • Tetanus
  • TNM002 (low dose)
  • +4 more
  • Shantou, Guangdong, China
  • +3 more
Nov 20, 2022

Diphtheria, Tetanus, Pertussis Trial in Xi'an (Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined

Not yet recruiting
  • Diphtheria
  • +2 more
  • Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed (Aged 6 Years and Older) (Tdcp)
  • +2 more
  • Xi'an, Shanxi, China
    Shaanxi Center for Disease Control and Prevention
Sep 25, 2023

COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in

Not yet recruiting
  • Follicular Lymphoma
  • Cellular immunity vs SARS-CoV-2
  • +6 more
  • Alessandria, IT, Italy
  • +13 more
Oct 10, 2023

Tetanus Patients in Fujian Province of China

Completed
  • Tetanus
    • Fuzhou, Fujian, China
      Fujian Provincial Hospital
    Nov 14, 2019

    Primary Ovarian Insufficiency Trial in Nantong (Resveratrol, Vitamin E)

    Recruiting
    • Primary Ovarian Insufficiency
    • Nantong, Jiangsu, China
      B ultrasound
    Jun 6, 2022

    Botulism Trial (A minimum of one 5 mL serum sample (up to three per enrolled subject) will be collected.)

    Enrolling by invitation
    • Botulism
    • Blood sample collection
    • (no location specified)
    Jan 30, 2023

    Postoperative Residual Curarization Trial in Poitiers (TOF scan train of four ratio monitoring, ITF device tetanus stimulation

    Completed
    • Postoperative Residual Curarization
    • TOF scan train of four ratio monitoring
    • ITF device tetanus stimulation monitoring
    • Poitiers, France
      CHU de Poitiers
    Jan 12, 2023

    Plasma Cell Myeloma Trial in Omaha (drug, procedure, biological)

    Active, not recruiting
    • Plasma Cell Myeloma
    • Omaha, Nebraska
      University of Nebraska Medical Center
    Nov 21, 2022

    Tetanus Trial in Bijie (TTVA, TT)

    Not yet recruiting
    • Tetanus
    • TTVA
    • TT
    • Bijie, Guizhou, China
      Center for Disease Control and Prevention, Qixingguan District,
    Nov 7, 2023

    Tetanus Trial in Bijie (TTVA, TT)

    Not yet recruiting
    • Tetanus
    • TTVA
    • TT
    • Bijie, Guizhou, China
      Center for Disease Control and Prevention, Qixingguan District,
    Nov 7, 2023

    Healthy Trial in Berlin (Nipocalimab, Tdap, PPSV23)

    Recruiting
    • Healthy
    • Berlin, Germany
      CRS Clinical Research Services Berlin GmbH
    Apr 24, 2023

    Intramuscular Injection, Pain Trial in Manisa (Helfer skin tap injection technique, Standard Injection technique)

    Completed
    • Intramuscular Injection
    • Pain
    • Helfer skin tap injection technique
    • Standard Injection technique
    • Manisa, Turkey
      Manisa Celal Bayar University
    Feb 27, 2023

    Atopic Dermatitis, Moderate-to-severe Atopic Dermatitis Trial in United States (Rocatinlimab, Placebo)

    Recruiting
    • Atopic Dermatitis
    • Moderate-to-severe Atopic Dermatitis
    • Canoga Park, California
    • +5 more
    Jun 15, 2023

    Dermatitis Atopic Trial (Amlitelimab, Placebo, Tdap vaccine)

    Not yet recruiting
    • Dermatitis Atopic
    • (no location specified)
    Aug 23, 2023

    Diphtheria, Tetanus Trial (Clodivac, Td-Impfstoff Merieux)

    Not yet recruiting
    • Diphtheria
    • Tetanus
    • Clodivac
    • Td-Impfstoff Merieux
    • (no location specified)
    Aug 9, 2022

    Diphtheria Trial in Schoenau Am Koenigssee, Milano, Santiago de Compostela (DTPa-HBV-IPV/Hib, DTaP5-HBV-IPV-Hib, Pneumococcal

    Completed
    • Diphtheria
    • DTPa-HBV-IPV/Hib
    • +2 more
    • Rosenheim, Bayern, Germany
    • +19 more
    Jan 24, 2023

    Postoperative Residual Curarization Trial in Poitiers (TOF SCAN, ITF)

    Completed
    • Postoperative Residual Curarization
    • TOF SCAN
    • ITF
    • Poitiers, France
      C.H.U. de Poitiers
    Jan 3, 2022

    Myofacial Pain Syndrome, Botulinum Toxin Trial in Cairo (Solvazinc 50mg, )

    Enrolling by invitation
    • Myofacial Pain Syndrome
    • Botulinum Toxin
    • Solvazinc 50mg
    • placebo
    • Cairo, Manial, Egypt
      Faculty of Dentistry
    Nov 3, 2022

    Tetanus, Diphtheria and Acellular Pertussis Vaccination Trial in Glassboro (Tdap)

    Not yet recruiting
    • Tetanus, Diphtheria and Acellular Pertussis Vaccination
    • Tdap
    • Glassboro, New Jersey
      ABO Plasma
    Dec 21, 2022